![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 19, 17430-17437, May 9, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Immunology Unit, Department of Cellular Biology and
Pathology, University of Barcelona School of Medicine, Institut
d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona
E-08036, Spain
CD229 (Ly9) is a cell surface
receptor selectively expressed on T and B lymphocytes, and it belongs
to the CD150 receptor family. Like other receptors of this family,
CD229 interacts with SAP/SH2D1a protein, mutation of which is
responsible for the fatal X-linked lymphoproliferative disease.
Receptors of the CD150 family function as costimulatory molecules,
regulating cytokine production and cytotoxicity. Thus, their signaling
and regulation in lymphocytes may be critical to an understanding of
the pathogenesis of the X-linked lymphoproliferative disease. Here we
show that CD229 interacts with the µ2 chain of the
AP-2 adaptor complex that links transmembrane proteins to
clathrin-coated pits. CD229 was the only member of the CD150 family
associated with AP-2. We also show that the µ2 chain
interacts with the Y470EKL motif of CD229. The
integrity of this site was necessary for CD229 internalization, but it
was not involved in SAP recruitment. Moreover, CD229 binds to the
AP-2 complex in T and B cell lines, and it is internalized rapidly from
the cell surface on T cells after antibody ligation. In contrast,
cross-linking of CD229 receptors with intact antibody inhibited CD229
internalization on B cells. However, when F(ab')2
antibodies were used, CD229 internalization was similar on T and B
cells, suggesting that Fc
receptors control CD229 cell surface
expression. Furthermore, CD229 was regulated by T cell receptor and B
cell receptor signaling because coligation with antibodies
against anti-CD3 and anti-IgM increased the rate of CD229 endocytosis.
These data suggest that CD229 cell surface expression on lymphocytes
surface is strongly and differentially regulated within the CD150
family members.
Recipient of a MAE/AECI fellowship from the
Ministerio de Asuntos Exteriores, Spain.
§
To whom correspondence should be addressed: Unidad de
Inmunología, Departamento Biología Celular, Facultad de
Medicina. C/Casanova 143, Barcelona E-08036, Spain. Tel.:
34-93-227-5400 (ext. 2338); Fax: 34-93-451-5272; E-mail:
mmartin@medicina.ub.es.
This article has been cited by other articles:
![]() |
S. Yun, W.-P. Hong, J. H. Choi, K. S. Yi, S.-K. Chae, S. H. Ryu, and P.-G. Suh Phospholipase C-{epsilon} Augments Epidermal Growth Factor-dependent Cell Growth by Inhibiting Epidermal Growth Factor Receptor Down-regulation J. Biol. Chem., January 4, 2008; 283(1): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhat, P. Eissmann, J. Endt, S. Hoffmann, and C. Watzl Fine-tuning of immune responses by SLAM-related receptors J. Leukoc. Biol., March 1, 2006; 79(3): 417 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Saborit-Villarroya, J. M. Del Valle, X. Romero, E. Esplugues, P. Lauzurica, P. Engel, and M. Martin The Adaptor Protein 3BP2 Binds Human CD244 and Links this Receptor to Vav Signaling, ERK Activation, and NK Cell Killing J. Immunol., October 1, 2005; 175(7): 4226 - 4235. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Romero, N. Zapater, M. Calvo, S. G. Kalko, M. A. de la Fuente, V. Tovar, C. Ockeloen, P. Pizcueta, and P. Engel CD229 (Ly9) Lymphocyte Cell Surface Receptor Interacts Homophilically through Its N-Terminal Domain and Relocalizes to the Immunological Synapse J. Immunol., June 1, 2005; 174(11): 7033 - 7042. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, J. M. Del Valle, I. Saborit, and P. Engel Identification of Grb2 As a Novel Binding Partner of the Signaling Lymphocytic Activation Molecule-Associated Protein Binding Receptor CD229 J. Immunol., May 15, 2005; 174(10): 5977 - 5986. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |